BNB PLUS CORP.

BNBX Nasdaq CIK: 0000744452

Company Information

Industry Services-Testing Laboratories
SIC Code 8734
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 50 HEALTH SCIENCES DRIVE, STONY BROOK, NY, 11790
Mailing Address 50 HEALTH SCIENCES DRIVE, STONY BROOK, NY, 11790
Phone 631-240-8800
Fiscal Year End 0930
EIN 592262718

Financial Overview

FY2016

$12.57M
Stockholders' Equity

Recent SEC Filings

Form Type Date Filed Document
4 Insider stock transaction report February 13, 2026 View on SEC
SCHEDULE 13G Passive beneficial ownership (>5%) February 13, 2026 View on SEC
3 Initial insider ownership report February 13, 2026 View on SEC
10-Q Quarterly financial report February 12, 2026 View on SEC
8-K Current report of material events February 5, 2026 View on SEC
8-K Current report of material events January 22, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment January 7, 2026 View on SEC
10-K Annual financial report December 22, 2025 View on SEC
S-1/A IPO registration amendment December 22, 2025 View on SEC
4 Insider stock transaction report December 16, 2025 View on SEC

Annual Reports

10-K December 22, 2025
  • BNB PLUS CORP. disposed of Applied DNA Clinical Labs (ADCL) and exited its clinical laboratory services business on June 27, 2025.
  • The company executed two reverse stock splits in March 2025 and June 2025, and raised capital through Direct Offerings and a Public Offering of Series Warrants.
View Analysis

Related Companies

Companies in the same industry (SIC: 8734)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.